Login
| TI Ref No : | 525382755 |
|---|---|
| Description : | 1753/2025- Acquisition Of B771- Bevacizumab [25 Mg/ml; 400 Mg/ 16 Ml; Conc For Sol For Infusion; Frs] Patients Undergoing Treatment And U41- Ustekinumab [45 Mg/ 0.5 Ml; Sun Inj; Syringe] - Patients Undergoing Treatment. contract Date: : 18-11-2025 contrac |
| Date : | 2025-11-23 |
| Deadline : | 2026-02-18 |
| Document Type : | Contracts |
